DK137924C - Fremgangsmaade til fremstilling af 1,4-dihydroquinoliner - Google Patents

Fremgangsmaade til fremstilling af 1,4-dihydroquinoliner

Info

Publication number
DK137924C
DK137924C DK111074A DK111074A DK137924C DK 137924 C DK137924 C DK 137924C DK 111074 A DK111074 A DK 111074A DK 111074 A DK111074 A DK 111074A DK 137924 C DK137924 C DK 137924C
Authority
DK
Denmark
Prior art keywords
dihydroquinolines
procedure
preparation
Prior art date
Application number
DK111074A
Other languages
English (en)
Other versions
DK137924B (da
Inventor
H Meyer
F Bossert
W Vater
K Stoepel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK137924B publication Critical patent/DK137924B/da
Application granted granted Critical
Publication of DK137924C publication Critical patent/DK137924C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK111074A 1973-03-03 1974-03-01 Fremgangsmaade til fremstilling af 1,4-dihydroquinoliner DK137924C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732310746 DE2310746A1 (de) 1973-03-03 1973-03-03 Verfahren zur herstellung von neuen 1,4-dihydrochinolinen sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
DK137924B DK137924B (da) 1978-06-05
DK137924C true DK137924C (da) 1978-10-30

Family

ID=5873779

Family Applications (1)

Application Number Title Priority Date Filing Date
DK111074A DK137924C (da) 1973-03-03 1974-03-01 Fremgangsmaade til fremstilling af 1,4-dihydroquinoliner

Country Status (21)

Country Link
US (1) US3910917A (da)
JP (1) JPS49134685A (da)
AT (1) AT328452B (da)
AU (1) AU473590B2 (da)
BE (1) BE811688A (da)
CA (1) CA1024517A (da)
CH (1) CH597191A5 (da)
DD (1) DD113002A5 (da)
DE (1) DE2310746A1 (da)
DK (1) DK137924C (da)
ES (1) ES423716A1 (da)
FR (1) FR2219786B1 (da)
GB (1) GB1421305A (da)
HU (1) HU167415B (da)
IE (1) IE39049B1 (da)
IL (1) IL44329A (da)
LU (1) LU69530A1 (da)
NL (1) NL7402750A (da)
PL (1) PL88760B1 (da)
SE (1) SE403285B (da)
ZA (1) ZA741353B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6210087A (ja) * 1985-07-03 1987-01-19 Shionogi & Co Ltd 4,7−ジヒドロチエノ〔2,3−b〕ピリジン誘導体,その製造法および循環器系疾患治療剤
FR2801310B1 (fr) * 1999-11-24 2004-04-16 Adir NOUVEAUX DERIVES DE DIHYDROFURO-[3,4-b]QUINOLEIN-1-ONES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
EP2268656A1 (en) * 2008-03-14 2011-01-05 Assaymetrics Limited Fluorogenic peptides and their method of production
US11511900B2 (en) 2021-03-18 2022-11-29 Osgood Industries, Llc Adjustable frame mount for process unit

Also Published As

Publication number Publication date
GB1421305A (en) 1976-01-14
DK137924B (da) 1978-06-05
CA1024517A (en) 1978-01-17
CH597191A5 (da) 1978-03-31
US3910917A (en) 1975-10-07
JPS49134685A (da) 1974-12-25
AT328452B (de) 1976-03-25
AU6597374A (en) 1975-08-28
ATA173474A (de) 1975-06-15
FR2219786B1 (da) 1977-11-10
IE39049B1 (en) 1978-07-19
DE2310746A1 (de) 1974-09-12
AU473590B2 (en) 1976-06-24
ZA741353B (en) 1975-01-29
IL44329A0 (en) 1974-06-30
DD113002A5 (da) 1975-05-12
PL88760B1 (da) 1976-09-30
LU69530A1 (da) 1974-10-09
FR2219786A1 (da) 1974-09-27
SE403285B (sv) 1978-08-07
HU167415B (en) 1976-04-28
IE39049L (en) 1974-09-03
ES423716A1 (es) 1976-04-01
BE811688A (fr) 1974-08-28
IL44329A (en) 1977-08-31
NL7402750A (da) 1974-09-05

Similar Documents

Publication Publication Date Title
SE7710600L (sv) Forfarande for framstellning av 1,3-bensoxazoler
DK139678B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
DK133051C (da) Analogifremgangsmade til fremstilling af 1,3-oxygenerede 8alfa-ostratriener
DK132707C (da) Analogifremgangsmade til fremstilling af 1,3,16,17-tetraoxygenerede 8alfa-ostratriener
DK140406B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
DK133050C (da) Analogifremgangsmade til fremstilling af 3,17,18-trihydroxy-1,3,5(10)-ostratriener
DK137389B (da) Analogifremgangsmåde til fremstilling af 11beta-substituerede delta4-østrener.
DK132795C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
SE401835B (sv) Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on
DK131855C (da) Fremgangsmade til fremstilling af 3,4-dihydropyridoner
DK137924C (da) Fremgangsmaade til fremstilling af 1,4-dihydroquinoliner
DK132329C (da) Fremgangsmade til fremstilling af cardenolid-3,alfa-(2'-desoxy-glycosider)
DK132221C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK138895B (da) Fremgangsmåde til fremstilling af 8-beta-(2'-pyrimidino-aminometyl)-ergolinderivater.
DK136619B (da) Fremgangsmåde til fremstilling af dihydrokanadensolid.
DK136183C (da) Fremgangsmade til fremstilling af 1-chlor-2,2,2-trifluorethyl-difluormethylether
DK348575A (da) Fremgangsmade til fremstilling af 9,11,15-trihydroxy-13,14-dehydro-prostaglandiner
DK138946B (da) Fremgangsmaade til fremstilling af 4-oxa-5-hydroxy-polycycloalkenon-(3)-er.
DK132703C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK352975A (da) Fremgangsmade til fremstilling af 3beta-(4-oxoalfa-l-rhamnosyl)-14beta-hydroxy-bufa-4,20,22-trienolid
DK134240B (da) Fremgangsmåde til fremstilling af bicyclomycin.
DK136603B (da) Fremgangsmåde til fremstilling af 1alfa-hydroxycholecalciferol.
NO138146C (no) Fremgangsmaate for fremstilling av 2,2`-anhydro-1beta-d-arabinfuranosyl-5-cytosin
DK131859C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK137087B (da) Fremgangsmåde til fremstilling af 3-keto-6-azido-4,6-bisdehydro-eller -1,4,6-trisdehydro-steroider.